Specific human secretory phospholipas A2 (sPLA2)and sPLA2-X were found to neutralize HIV-1 through degradation of the viral membrane. Catalytic function was required for anti-viral activity, and target cells of infection were unaffected. sPLA2-X potently reduced gene transfer of HIV-1 Env-pseudotyped lentiviral vectors and inhibited both CCR5- and CXCR4-tropic HIV-1 virus replication in human CD4+ T cells. Virions resistant to damage by antibody and complement were sensitive to lysis by sPLA2-X, suggesting a novel mechanism of antiviral surveillance independent of the acquired immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI005075-03
Application #
7592423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2007
Total Cost
$295,946
Indirect Cost
City
State
Country
United States
Zip Code
Kim, Jae-Ouk; Chakrabarti, Bimal K; Guha-Niyogi, Anuradha et al. (2007) Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2. J Virol 81:1444-50